These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 31872481)
1. Adherence to infectious disease screening and immunization guidelines when treating non-malignant immune-mediated hematologic disorders. Malpica-Castillo LE; Palmer S; Zhu A; Deal AM; Chen SL; Moll S Am J Hematol; 2020 Mar; 95(3):E72-E75. PubMed ID: 31872481 [No Abstract] [Full Text] [Related]
2. Immunology 101: fundamental immunology for the practicing hematologist. Carty SA Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):281-286. PubMed ID: 34889423 [TBL] [Abstract][Full Text] [Related]
3. Successes and failures of intravenous immunoglobulin. Atrah HI; Crawford RJ; Gabra GS; Mitchell R Scand J Haematol; 1985 Apr; 34(4):345-7. PubMed ID: 4001865 [TBL] [Abstract][Full Text] [Related]
4. [High-dose intravenous immunoglobulins in the treatment of immune blood cytopenia. Mechanisms of action, indications and results]. Aymard JP; Ferry R; Janot C; Schooneman F; Streiff F Ann Med Interne (Paris); 1990; 141(8):689-97. PubMed ID: 2091513 [No Abstract] [Full Text] [Related]
5. TLI-based reduced-intensity conditioning hematopoietic SCT for children and adolescents with high-risk nonmalignant disorders. Hussein AA; Al-Mousa A; Khattab E; Al-Zaben A; Frangoul H Bone Marrow Transplant; 2015 Mar; 50(3):452-4. PubMed ID: 25419694 [No Abstract] [Full Text] [Related]
6. Intersections of hematology, immunology, dermatology and infectious diseases. Dale DC Curr Opin Hematol; 2015 Jan; 22(1):1-2. PubMed ID: 25469835 [No Abstract] [Full Text] [Related]
7. Therapeutic Apheresis in Hematologic, Autoimmune and Dermatologic Diseases With Immunologic Origin. Bambauer R; Latza R; Burgard D; Schiel R Ther Apher Dial; 2016 Oct; 20(5):433-452. PubMed ID: 27633388 [TBL] [Abstract][Full Text] [Related]
8. [Therapeutic plasmapheresis in immunologic diseases]. Selset G Tidsskr Nor Laegeforen; 1987 Oct; 107(29):2516-20. PubMed ID: 3445248 [No Abstract] [Full Text] [Related]
9. Preventing infectious complications when treating non-malignant immune-mediated hematologic disorders. Malpica L; van Duin D; Moll S Am J Hematol; 2019 Dec; 94(12):1396-1412. PubMed ID: 31571266 [TBL] [Abstract][Full Text] [Related]
10. Cytokines in Hematology, Oncology, and Immunology. 3rd International Symposium. Hannover, June 23-26, 1993. Abstracts. Ann Hematol; 1993 Jun; 66(6):A75-117. PubMed ID: 8100451 [No Abstract] [Full Text] [Related]
11. Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients. Butler CE; Noel S; Hibbs SP; Miles D; Staves J; Mohaghegh P; Altmann P; Curnow E; Murphy MF Transfusion; 2015 Aug; 55(8):1964-71. PubMed ID: 25906831 [TBL] [Abstract][Full Text] [Related]
12. A Retrospective Study of Patient Factors That Indicate Provider Nonadherence to an Institutional Clostridium difficile Treatment Guideline. Siehnel JT; Lavigne JE; Rightmier EA; Bossard WT; Li N; Slish JC J Pharm Pract; 2018 Apr; 31(2):169-174. PubMed ID: 28569127 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B immunisation of household contacts: retrospective study of vaccine coverage. Richardson G; Evans MR; Westmoreland D J Epidemiol Community Health; 2001 Dec; 55(12):934-5. PubMed ID: 11707490 [No Abstract] [Full Text] [Related]
14. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Snowden JA; Sánchez-Ortega I; Corbacioglu S; Basak GW; Chabannon C; de la Camara R; Dolstra H; Duarte RF; Glass B; Greco R; Lankester AC; Mohty M; Neven B; de Latour RP; Pedrazzoli P; Peric Z; Yakoub-Agha I; Sureda A; Kröger N; Bone Marrow Transplant; 2022 Aug; 57(8):1217-1239. PubMed ID: 35589997 [TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin therapy in immunohematological disorders. Choudhry VP; Mahapatra M; Kashyap R Indian J Pediatr; 1998; 65(5):681-90. PubMed ID: 10773923 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders. Current practice in Europe in 1996 and proposals for an operational classification. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT). Schmitz N; Gratwohl A; Goldman JM Bone Marrow Transplant; 1996 Apr; 17(4):471-7. PubMed ID: 8722341 [TBL] [Abstract][Full Text] [Related]
17. New-onset food allergy following cord blood transplantation in adult patients. Mori T; Kato J; Sakurai M; Hashimoto N; Kohashi S; Hashida R; Saburi M; Kikuchi T; Yamane Y; Hoshino K; Okamoto S Bone Marrow Transplant; 2016 Feb; 51(2):295-6. PubMed ID: 26457912 [No Abstract] [Full Text] [Related]
18. Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease. O'Sullivan LA; Liongue C; Lewis RS; Stephenson SE; Ward AC Mol Immunol; 2007 Apr; 44(10):2497-506. PubMed ID: 17208301 [TBL] [Abstract][Full Text] [Related]
19. Immunization after renal transplantation: current clinical practice. Struijk GH; Lammers AJ; Brinkman RJ; Lombarts MJ; van Vugt M; van der Pant KA; Ten Berge IJ; Bemelman FJ Transpl Infect Dis; 2015 Apr; 17(2):192-200. PubMed ID: 25662181 [TBL] [Abstract][Full Text] [Related]
20. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Ljungman P; Bregni M; Brune M; Cornelissen J; de Witte T; Dini G; Einsele H; Gaspar HB; Gratwohl A; Passweg J; Peters C; Rocha V; Saccardi R; Schouten H; Sureda A; Tichelli A; Velardi A; Niederwieser D; Bone Marrow Transplant; 2010 Feb; 45(2):219-34. PubMed ID: 19584824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]